Objective: To present the main short, medium and long-term neurological repercussions of insomnia on the human body. Methodology: An integrative review was carried out in the databases indexed to Google Scholar and PUBMED, using as inclusion criteria articles published between 2009 and 2022, in English and Portuguese, and as exclusion criteria, duplicate and unrelated articles with the theme. Results: 23 articles were used, in which it was possible to identify the relationship between insomnia and the development of various diseases at all stages of life and in damage to school activities, work and even social relationships, cause metabolic syndrome disorders and cardiovascular disease and providing future neurodegenerative diseases. Final Considerations: It was possible to identify that insomnia has great potential to impact the individual's quality of life or to aggravate other diseases, as it is related to the development of various somatic and psychosocial pathologies, including anxiety, depression, memory problems, diseases chronic diseases such as cardiovascular diseases, hypertension, diabetes, cancer and decreased quality of life.

Objective: To investigate the forms of treatment of migraine symptoms. Methods: This is a qualitative bibliographic review, which used the keywords "migraine" and "treatment" in Portuguese and English. It obtained articles from the Up to Date, Pubmed, Scielo and Medline databases between 2010 and 2020. Results: Migraine is characterized by the presence or absence of aura in addition to the appearance of throbbing pain of unilateral location in most cases with presence of nausea, photophobia and phonophobia. It, popularly known as migraine, is present in 15 to 25% of the population, being the second most common form of headache, behind only tension headache. There are many risk factors and mechanisms for the development of migraine. As well as, its possible classifications that are based on clinical diagnosis, based on them, the specific therapeutic approach is based on lifestyle changes, complementary therapies and pharmacotherapy. Conclusion: The treatment of migraine if applied at the right time prevents disease progression and ensures a better quality of life for patients.

Objetivo: analizar los principales trastornos neurológicos derivados de la infección por el virus SARS-CoV-2 (síndrome respiratorio agudo severo coronavirus 2) a través de una revisión integradora. Metodología: se trata de un estudio integrador de revisión bibliográfica. Para la selección de artículos se utilizaron dos bases de datos: PUBMED y Scielo, y se establecieron los siguientes criterios de inclusión: estudios de reporte de caso y estudios clínicos, realizados en seres humanos, disponibles en inglés, español y portugués, atribuyéndole el corte de tiempo de 1 año (2020-2021). La muestra final utilizada en esta revisión consistió en 36 artículos. Resultados y discusión: aunque el objetivo principal es el sistema respiratorio humano, el coronavirus tiene potencial neurotrópico y neuroinvasivo, teniendo la capacidad de llegar al sistema nervioso central (SNC). Así, los estudios han demostrado asociaciones entre la infección por SARS-Cov-2 y la aparición de dolor de cabeza, encefalopatía, enfermedad cerebrovascular, hemorragia cerebral, encefalomielitis, alteración de la conciencia y delirio, convulsiones tónico-clónicas, alteración del olfato y del gusto, síndrome de Guillain-Barré, rabdomiólisis, enfermedad de Parkinson, Alzheimer y esclerosis múltiple. Conclusión: de la revisión bibliográfica actual se infiere que los índices de afectación neurológica en los casos de COVID-19 son significativos y exigen el desarrollo de más estudios sobre el tema.